Petauri
in the news


Petauri™ Acquires FORCE Communications

NASHVILLE, Tenn. (February 14, 2024) — Petauri, a purpose-built pharmaceutical services platform, announced its acquisition of FORCE Communications and its 3 independent companies, DRIVE, MOMENTUM, and PROPEL, which bring science to life on behalf of clients and their medical innovations.

Read More >


Petauri™ Launches Petauri Advisors

Rapidly growing pharmaceutical services platform expands presence in life sciences consulting with the addition of key industry leadership.

NASHVILLE, Tenn. (January 18, 2024) — Petauri, a purpose-built pharmaceutical services platform, announced today the launch of Petauri Advisors, with industry veteran Steve O’Malley as President.

Read More >


Petauri™ Elects William Fleming and James Robinson to Its Board of Directors

Rapidly growing pharmaceutical services platform expands board leadership with experts in health insurance, public health policy,
and life sciences innovation.

NASHVILLE, Tenn. (December 6, 2023) — Petauri Health, a purpose-built pharmaceutical services platform, announced today that two highly regarded healthcare executives, William Fleming and James Robinson, have been elected as members
of the company’s Board…

Read More >


Petauri™ Health Adds Nicole Kline and Lauren Gonzalez to Senior Leadership Team

Rapidly growing pharmaceutical services platform enhances corporate center with key strategic talent specializing in legal and human resources matters.

NASHVILLE, Tenn. (November 29, 2023) — Petauri Health, a purpose-built pharmaceutical services platform, today announced the addition of two industry professionals who expand its senior leadership team.

Nicole Kline, Petauri’s new Vice President, General Counsel…

Read More >


Petauri™ Welcomes 3 Top‑Tier Leaders

Rapidly growing Petauri Health adds exceptional talent to its executive roster. NEW YORK September 21, 2023 — Petauri Health, a New York-based, purpose-built pharmaceutical services platform, announced today that it has added to its executive ranks with 3 experienced leaders who straddle information technology, operations, and finance. Jeff Petet, CHCIO, has been named SVP, Information…

Read More >


Petauri™ Welcomes Mridul Malhotra

Rapidly growing Petauri Health adds top talent to its executive team NEW YORK July 12, 2023 — Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced today that it has named Mridul Malhotra to the dual role of Chief Strategic Officer (CSO) and Global Head: Evidence, Value, and Access (EVA). In this newly created…

Read More >


Petauri™ Acquires The Kinetix Group

Petauri Health’s initial acquisition marks a key milestone in its mission to offer integrated commercialization solutions. NEW YORK June 13, 2023 — Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced today that it has acquired The Kinetix Group, also known as TKG. Founded by John Strapp and Sarah McNulty, The Kinetix Group is…

Read More >


Our CEO’s perspective on 2 key topics that will impact payer strategy in 2023.

PM360 asked experts in developing market access strategies how the Inflation Reduction Act will impact drug pricing negotiation and other access-related issues as well as what other big trends in the space will force the industry to rethink its strategies.  See how our own Dan Renick responded:

Read More >


Oak Hill Capital Announces Formation of Petauri Health

Oak Hill Capital and life sciences industry leader Dan Renick team up to create new organization offering integrated commercialization solutions. NEW YORK February 1st, 2023 – Oak Hill Capital, a New York-based middle-market private equity firm, announced today that it has partnered with Dan Renick to launch Petauri Health (“Petauri” or “the Company”), a purpose-built…

Read More >